Are Ending the HIV Epidemic goals attainable across race/ethnic groups, risk groups, and settings?
Project Number1R01AA031644-01A1
Former Number1R01AA031644-01
Contact PI/Project LeaderBRAITHWAITE, RONALD SCOTT
Awardee OrganizationNEW YORK UNIVERSITY SCHOOL OF MEDICINE
Description
Abstract Text
Project Abstract
In collaboration with the Shelby County Health Department, which has jurisdiction over Memphis as well as
rural northwest Mississippi and Arkansas, we propose to inform policy decisions towards improving HIV
outcomes for population-level and subgroup-specific HIV goals in three diverse settings that together typify
high incidence locations in the U.S. HIV epidemic (New York City, Memphis, and northwest Mississippi).
We will use mathematical modeling to simulate alternative ways to distribute resources across interventions,
settings, and target populations to reduce HIV incidence and improve overall health. Our analyses will be
distinguished by incorporating screening and responding to CASM conditions (Conditions of Alcohol,
Substance and Mood), measures of inequality-aversion (i.e., willingness to trade-off some aggregate benefit in
order to distribute it more equally) towards vulnerable subgroups, and the promising new modalities of long-
acting-injectable PrEP and ART. Our partners at the Shelby County Health Department and their larger group
of stakeholders will provide context on local HIV infection patterns and feasibility and acceptability constraints
to inform modeling analyses.
Public Health Relevance Statement
Project Narrative
In collaboration with the Shelby County Health Department and other health jurisdictions, we will simulate
alternative policies to maximally reduce HIV incidence and improve overall health in three settings (New York
City, Memphis, and northwest Mississippi). We will place special emphasis on the role of alcohol, substance
and mood disorders on HIV transmission and progression. We will also incorporate inequality-aversion
measures to address uneven health burden in vulnerable subgroups.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AIDS preventionAddressAdherenceAdjusted Life YearsAlcoholsArkansasBenchmarkingBlack AmericanBudgetsCaringCitiesCollaborationsCountryCountyDiagnosisEpidemicEthnic PopulationFundingGoalsHIVHIV InfectionsHIV riskHealthIncidenceInequalityInequityInjectableInternationalInterventionLinkLocationMeasuresMental HealthMississippiModalityModelingMood DisordersMoodsNew York CityNewly DiagnosedOutcomePatternPersonsPoliciesPopulationQuality-Adjusted Life YearsRaceRecommendationResource AllocationResourcesRiskRisk BehaviorsRoleRuralSpecificitySubgroupTarget PopulationsTestingTimeViral Load resultWorkacceptability and feasibilitycaucasian Americancofactorimprovedinsightinterestmathematical modeloutcome disparitiespre-exposure prophylaxispreventracial populationscreeningtransmission processwillingnesswillingness to pay
National Institute on Alcohol Abuse and Alcoholism
CFDA Code
273
DUNS Number
121911077
UEI
M5SZJ6VHUHN8
Project Start Date
15-September-2024
Project End Date
30-June-2029
Budget Start Date
15-September-2024
Budget End Date
30-June-2025
Project Funding Information for 2024
Total Funding
$820,845
Direct Costs
$517,366
Indirect Costs
$303,479
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Allergy and Infectious Diseases
$820,845
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R01AA031644-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01AA031644-01A1
Patents
No Patents information available for 1R01AA031644-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01AA031644-01A1
Clinical Studies
No Clinical Studies information available for 1R01AA031644-01A1
News and More
Related News Releases
No news release information available for 1R01AA031644-01A1
History
No Historical information available for 1R01AA031644-01A1
Similar Projects
No Similar Projects information available for 1R01AA031644-01A1